{
  "retracted": false,
  "timestamp": 1517443200000,
  "updates": [
    {
      "timestamp": 1575011511302,
      "identifier": {
        "doi": "10.1016/j.jad.2017.10.040"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.jad.2016.08.029"
  },
  "journal": "Journal of Affective Disorders",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]"
}
